Coloplast AS (CLPBF) Q1 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ...
Coloplast AS (CLPBF) reports robust 8% organic growth and a 27% EBIT margin, while addressing challenges in Interventional ...
Coloplast targets 8%-9% organic growth for FY 2025 amid Kerecis expansion and new launches
Q1 2025. Management View. CEO Kristian Villumsen highlighted 8% organic growth and a reported EBIT margin of 27% for Q1 2025, w ...
Coloplast Finance B.V. - Interim Financial Report, Q1 2024/25
Growth in Interventional Urology was negatively impacted by a voluntary product recall in Bladder Health and Surgery (around DKK 25 million in Q1), partly offset by solid performance in Endourology.
Sleep Apnea Diagnostic Systems Market Growth USD 6,223.7 Million by 2025 to 2035 at a 3.3% Driven by Technological Advancements and Rising Awareness
As per Future Market Insights, PSG devices are expected to be the most preferred sleep apnea diagnostic systems during the ...